JP Stocks

3695.T Stock Falls 0.95% on May 4, 2026 as GMO Platform Faces Headwinds

Key Points

3695.T stock fell 0.95% to ¥1,663 on May 4, 2026 amid earnings pressure.

Net income declined 40.4% year-over-year with operating income down 46.6%.

P/E ratio of 39.78 remains elevated versus Industrials sector average.

Dividend yield of 3.58% provides income support despite operational challenges.

Be the first to rate this article

GMO Product Platform, Inc. (3695.T) closed at ¥1,663 on May 4, 2026, down 0.95% from the previous session on the Tokyo Stock Exchange (JPX). The 3695.T stock decline reflects broader market pressures affecting the Industrials sector, where the company operates in specialty business services. With a market cap of ¥7.32 billion and trading volume of just 2,300 shares, liquidity remains thin. The company, formerly known as GMO Research, Inc., provides audience engagement platforms and survey services across Asia. Earnings are scheduled for May 14, 2026, which may provide clarity on recent performance headwinds.

3695.T Stock Price Action and Technical Signals

The 3695.T stock opened at ¥1,683 and traded between ¥1,646 and ¥1,683 during the session. The 16 yen decline represents a modest pullback from the 50-day moving average of ¥1,699.90. However, the stock remains significantly below its 200-day average of ¥2,055.83, signaling sustained downward pressure over the medium term.

Technical indicators show mixed signals. The Relative Strength Index (RSI) sits at 46.70, suggesting neither overbought nor oversold conditions. The MACD histogram at 5.56 indicates slight bullish momentum, though the signal line remains negative. Bollinger Bands place the stock near the middle band at ¥1,657.40, with upper resistance at ¥1,681.38 and lower support at ¥1,633.42. Track 3695.T on Meyka for real-time technical updates and price alerts.

Valuation Metrics and Earnings Outlook for 3695.T Stock

The 3695.T stock trades at a P/E ratio of 39.78, which is elevated compared to the Industrials sector average of 17.77. The price-to-book ratio stands at 2.84, suggesting the market values the company at nearly three times its tangible assets. Earnings per share (EPS) reached ¥41.81, though net profit margins are thin at just 2.28%.

Looking ahead, earnings are scheduled for May 14, 2026. Recent financial growth shows concerning trends: net income fell 40.4% year-over-year, while operating income dropped 46.6%. Revenue declined slightly by 1.79%. These metrics suggest operational challenges that may weigh on the stock until management provides updated guidance and explains the earnings decline.

Market Sentiment and Trading Activity for 3695.T

Trading volume for 3695.T stock remains depressed at 2,300 shares, well below the 30-day average of 6,091 shares. This represents just 37.8% of normal volume, indicating weak investor interest. The Money Flow Index (MFI) at 64.71 suggests accumulation pressure, though low volume limits conviction.

The stock has declined 42.5% over the past 12 months and 22.4% year-to-date, reflecting sustained selling pressure. The year-high of ¥2,883 and year-low of ¥1,638 show the stock has recovered slightly from lows but remains far from peaks. Meyka AI rates 3695.T with a grade of B+, factoring in sector performance, financial metrics, and analyst consensus. This grade suggests neutral positioning despite recent weakness.

Financial Health and Dividend Yield

GMO Product Platform maintains a solid balance sheet with a debt-to-equity ratio of 0.27, indicating conservative leverage. The current ratio of 1.18 shows adequate short-term liquidity, though not exceptional. Cash per share stands at ¥1,327.33, providing a cushion for operations.

The company pays a dividend of ¥59.52 per share, translating to a 3.58% yield at current prices. This dividend has grown 5.2% year-over-year, demonstrating management’s commitment to shareholders despite earnings pressure. Return on equity (ROE) of 7.05% and return on assets (ROA) of 1.65% are modest, reflecting the challenges in converting assets into profits in the competitive survey and research services market.

Final Thoughts

3695.T stock faces a critical juncture as it approaches earnings on May 14, 2026. The ¥1,663 price point reflects investor concerns about declining profitability and weak trading momentum. While the B+ grade from Meyka AI suggests neutral positioning, the 40% drop in net income and 46% fall in operating income cannot be ignored. The 3.58% dividend yield provides some income support, but shareholders should monitor the earnings call closely for management’s turnaround strategy. The thin trading volume and elevated P/E ratio suggest limited institutional support. Investors should await earnings clarity before making significant portfolio moves in this Industrials sector stock.

FAQs

Why did 3695.T stock decline 0.95% on May 4, 2026?

The decline reflects market pressures and operational challenges. Net income fell 40.4% year-over-year and operating income dropped 46.6%, signaling difficulties in the specialty business services sector.

What is the current price and P/E ratio for 3695.T stock?

3695.T closed at ¥1,663 with a P/E ratio of 39.78, significantly above the Industrials sector average of 17.77, suggesting the market anticipates future recovery or growth.

When are earnings announced for GMO Product Platform?

Earnings are scheduled for May 14, 2026. This announcement is critical for investors seeking clarity on the turnaround strategy and whether profit declines are temporary or structural.

What is the dividend yield for 3695.T stock?

The dividend yield is 3.58% with a per-share dividend of ¥59.52, up 5.2% year-over-year. This demonstrates management’s commitment to shareholders despite recent earnings pressure.

What grade does Meyka AI assign to 3695.T stock?

Meyka AI rates 3695.T with a B+ grade, considering S&P 500 benchmarks, sector performance, financial growth, and analyst consensus. This suggests neutral positioning despite recent weakness.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)